SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis

BACKGROUND: Sodium–glucose transporter 2 inhibitors (SGLT2-I) could modulate atherosclerotic plaque progression, via down-regulation of inflammatory burden, and lead to reduction of major adverse cardiovascular events (MACEs) in type 2 diabetes mellitus (T2DM) patients with ischemic heart disease (I...

Descripción completa

Detalles Bibliográficos
Autores principales: Sardu, Celestino, Trotta, Maria Consiglia, Sasso, Ferdinando Carlo, Sacra, Cosimo, Carpinella, Gerardo, Mauro, Ciro, Minicucci, Fabio, Calabrò, Paolo, D’ Amico, Michele, D’ Ascenzo, Fabrizio, De Filippo, Ovidio, Iannaccone, Mario, Pizzi, Carmine, Paolisso, Giuseppe, Marfella, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067292/
https://www.ncbi.nlm.nih.gov/pubmed/37005586
http://dx.doi.org/10.1186/s12933-023-01814-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067292/
https://www.ncbi.nlm.nih.gov/pubmed/37005586
http://dx.doi.org/10.1186/s12933-023-01814-7

Ejemplares similares